Inhaled cisplatin dry powder added to anti-PD1 therapy increases antitumour activity in lung cancer

Davenne, T.; P., Percier; Larbanoix, Lionel; Moser, Michaël; léo, O.; Meylan, E.; Goriely, S.; Gérard, P.; Wauthoz, N.; Laurent, Sophie; Amighi, K.; Rosière, R.

Download

Article (Scientific journals)

Inhaled cisplatin dry powder added to anti-PD1 therapy increases antitumour activity in lung cancer

Davenne, T.; P., Percier; Larbanoix, Lionel et al.

2023 • In Journal of Controlled Release

Peer reviewed

Permalink
https://hdl.handle.net/20.500.12907/46086

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

2022DavenneetalJCR.pdf

Author postprint (9.85 MB)

Download

All documents in ORBi UMONS are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Life sciences: Multidisciplinary, general & others
Chemistry

Author, co-author :

Davenne, T.

P., Percier

Larbanoix, Lionel ; Université de Mons - UMONS > Unités externes > Center for Microscopy and Molecular Imaging

Moser, Michaël ; Université de Mons - UMONS > Unités externes > SA CILBIOTECH

léo, O.

Meylan, E.

Goriely, S.

Gérard, P.

Wauthoz, N.

Laurent, Sophie ; Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Chimie générale, organique et biomédicale

Amighi, K.

Rosière, R.

Language :

English

Title :

Inhaled cisplatin dry powder added to anti-PD1 therapy increases antitumour activity in lung cancer

Publication date :

2023

Journal title :

Journal of Controlled Release

Peer reviewed :

Peer reviewed

Research unit :

M108 - Chimie générale, organique et biomédicale

Research institute :

Biosciences
R550 - Institut des Sciences et Technologies de la Santé

Available on ORBi UMONS :

since 26 June 2023

Statistics

Number of views

12 (1 by UMONS)

Number of downloads

26 (0 by UMONS)

More statistics